Record margin, but revenue growth falters; organic PAT masks EPR windfall
The verdict, the claims that held up, the sharpest analyst exchanges, and the risks — the earnings call, decoded from the transcript.
Hold
confidence 6/10
Grade B
Met margin target (18%+), beat it (21.7% OPM); revenue just at 20% guidance floor; new product ramps on track (TPO Q2, rCB Q3).
Cautiously Optimistic
next 1–2 quarters
Optimistic
multi-year
Strong Q1 margins (21.7% OPM, 13.1% NPM) validate operational strategy; however, revenue growth at guidance floor (19.9% vs 20%+ prior), QoQ revenue down 0.5%, and ~₹5 Cr PAT from one-time EPR monetization mask organic slowdown. Consumer segment weakness (-20% volume) and geopolitical headwinds temper near-term. Long-term (Vision 2029 at ₹1,000 Cr on 25%+ CAGR) is ambitious but execution-dependent.
₹156.2 Cr
Revenue · +19.9% YoY₹20.6 Cr
Reported PAT · +75.2% YoYExpanding
Margins · vs guidance: MixedDid the claims hold up?
Record EBITDA exceeding ₹30 crores; PAT surpassing ₹20 crores.
METEBITDA ~₹34 Cr (21.7% OPM), PAT ₹20.6 Cr (13.1% NPM). ✓ Supported; highest in at least 2–3 years.
Revenue increased by 18–20% YoY on standalone basis.
MET19.9% YoY growth delivered. ✓ Supported; just below prior 20–25% guidance.
Industrial segment grew 58% YoY in revenue.
OVERSTATEDIndustrial segment volume +27% YoY; revenue benefit from higher realization + MRP/reclaim growth (28%/37% volumes). Mix of volume and value-add; 58% claim likely includes exports (+46%) and new customer adds. Plausible but overstated for core industrial segment.
PCMB revenue increased threefold to ₹12 Cr from ₹4 Cr YoY.
METQ1 FY27 PCMB revenue ₹12 Cr vs Q1 FY26 ₹4 Cr. ✓ Supported. Capacity now 18,000 tpa (up from 6,000 tpa initial).
Margins 18%+ sustainable; no inventory gains.
OVERSTATEDQ1 delivered 21.7% OPM; management guided 18–20% for FY27 (conservative). Material+inventory cost ratio 46% of sales (Q1) vs 51%+ prior year. Margin driven by raw material optimization + value-add mix, not one-offs. But ~₹5 Cr of ₹20.6 Cr PAT from EPR monetization (non-recurring).
Earnings quality
What changed since the last call
FY27 revenue guidance narrowed
DowngradePrior: 20–25% YoY growth. Q1 delivered 19.9% YoY; management guided ₹670–700 Cr FY27 revenue (~16–17% growth for full year), implying deceleration after strong ramps in Q2–Q3.
Margin guidance conservative
NeutralPrior: 18%+ EBITDA target. Q1 delivered 21.7% OPM; guidance reset to 18–20%, citing front-ended expansion costs. Suggests 18–20% is sustainable midpoint, not 21%+.
Consumer segment impact
DowngradeNot called out in prior guidance. Q1 volume down 20% due to raw material cost shocks; management expects recovery when market stabilizes, but timing unclear.
International investments ramping
NewSouth Africa, Saudi, Chile now active (₹27 Cr capex Q1). Prior guidance indicated international as hedge; now visible cost drag on near-term margins.
The Q&A
Moderate pressure on margins and EPR accounting; analysts pressed on sustainability of 21%+ margins (management deflected to 18–20% guidance), EPR's P&L treatment (management clarified one-time vs recurring), and near-term headwinds (geopolitical, monsoon delays). Management held firm on Vision 2029 roadmap; tone was confident but evasive on geopolitical risks.
Margin sustainability — Dheeraj Ram, 360 ONE Capital
PartialInventory gains marginal. Margin expansion from raw material optimization and value-add product mix (systemic, not one-off). Expect 18–20% blended for year due to expansion capex costs.
EPR accounting — Deepak Poddar, Sapphire Capital
AnsweredMonetized 100k units from prior years' accrual. Recurring EPR ₹25–30 Cr annually at PBT level. This quarter's ₹25 Cr converted to cash; impact already in prior P&L.
Geopolitical and expansion risk — Mihir, Equirus
DodgedDetails confidential. Chile and South Africa secure tire supply hedge. Saudi a natural extension of Oman base. Core investment remains India. ₹100 Cr FY27–28 plan; may increase if demand strong.
Infra segment outlook — Mihir, Equirus
AnsweredBitumen shortage actually helped (contractors prefer cheaper rubberized bitumen). Q1 is peak season; Q2 typically weak (monsoon). But using modified bitumen to work through. Demand momentum expected to hold.
Consumer segment recovery — Navani Naredi, Naredi Investment
PartialConsumer 8–10% of revenue; hedge is diversification across industrial, infra, steel, PCMB, TPO, rCB. Price issue is with binder (outside control). Business intact; demand there.
EPR P&L treatment — Viraj, MoneyGrow
Partial₹156 Cr includes Q1 accrued EPR income only. ₹20.6 Cr PAT includes ₹5 Cr from prior year EPR monetization. Two different things; cannot mix.
Organic profitability — Ajit Sethi, investor
DodgedNumbers correct, but EPR is integral to recycling business, not separable. Treat it as core earnings.
FY27 guidance — Saurav Gupta, investor
AnsweredFY27 revenue ₹670–700 Cr; EBITDA margins 18–20%. Q1 22% not repeatable; guidance conservative to cover expansion costs.
Margin decomposition — Amit Rathi, Capital
PartialMain contribution gross margin (raw material optimization + value-add sales). Some efficiencies from scale. Cannot isolate exact numbers.
Guidance
FY27 revenue ₹670–700 Cr
HighQ1 ₹156 Cr × 4 = ₹624 Cr annualized, but Q2–Q4 expected higher as TPO/rCB ramp. Implies ₹670–700 Cr achievable; ~16–17% FY growth.
EBITDA margins 18–20% for FY27
HighConservative relative to Q1's 21.7% OPM. Accounts for expansion capex (front-ended costs), new geographies (South Africa, Saudi early losses), and normalization of one-time benefits.
₹100 Cr over FY27–28 (₹60 Cr FY27, ₹40 Cr FY28)
HighPartially funded by internal accruals; limited debt possible. Covers MRP expansion (+3.5k tpa), TPO, rCB, PCMB expansion, international sites.
Risks the call surfaced
Geopolitical exposure
HighBitumen shortage created near-term demand boost (rubberized bitumen), but sustained disruption could choke infra segment (7% YoY growth). Saudi facility start delayed by geopolitical normalization need. Oman margins recovering post-crisis.
Consumer segment weakness
MediumConsumer segment (8–10% of revenue) down 20% volume in Q1 due to binder/synthetic grass price spikes. Contractors delaying turfing projects. Recovery timeline unspecified; demand may take quarters to normalize.
Margin sustainability
MediumManagement guided 18–20% EBITDA for FY27 (vs Q1's 21.7% OPM), citing expansion capex, new geographies, and one-time benefits. Risk that margins normalize below Q1 as new plants ramp and geopolitical benefits fade.
One-time EPR benefit inflating PAT
MediumQ1 PAT ₹20.6 Cr includes ~₹5 Cr from prior year EPR credit monetization (accrual taken in prior years). Organic PAT ~₹15.6 Cr (10% NPM). Recurring EPR ₹25–30 Cr at PBT level (not PAT), so Q1 organic growth overstated.
International expansion execution
HighSouth Africa Phase 1 completed Q1, breakeven expected Q2; Phase 2 (9k tpa crumb rubber) equipment en route, production Q2–Q3. Saudi facility start delayed pending geopolitical normalization. Chile subsidiary established but strategic details withheld. Collective ₹27 Cr capex Q1 is early-stage investment; profitability unproven.
Management
Score 6/10. Clear on strategy and capex roadmap; detailed on segment performance. Evasive on geopolitical risks and Chile rationale ('details confidential'). Defensive on EPR accounting and margin sustainability. Met FY26 guidance; Q1 delivered margin target (18%+ guidance vs 21.7% delivered). Revenue growth 19.9% YoY just at guidance floor (20%+). Capex on track (₹27 Cr Q1 vs ₹60 Cr FY27 plan). New products launching (TPO Q2, rCB Q3). Mixed track record.
1 · Q2 FY27 (Jul–Sep 2026)
TPO facility commercial sales launch; rCB production to start Q3.
2 · Q3 FY27 (Oct–Dec 2026)
MRP capacity +3,500 tpa to 20,000 tpa commissioned; rCB production ramp.
3 · FY27 closing (Mar 2027)
Management targeting ₹670–700 Cr revenue, 18–20% EBITDA margins.
Long-term (Vision 2029 at ₹1,000 Cr on 25%+ CAGR) is ambitious but execution-dependent.
Record Margins, Slowing Growth — and the Street Already Priced It In
PAT surged 75% but relies on a ₹5 crore one-time EPR benefit; organic profit grew ~35%. Revenue missed the guidance floor at 19.9% YoY, and the company reset full-year expectations downward. The market's 9.4% sell-off by day 3 tells the real story.
₹20.6 Cr
+75.2% YoY
~₹5 Cr
prior-year accrual monetized
~₹15.6 Cr
10% NPM; run-rate number
On the surface, a 75% PAT jump looks like a blowout. But the real story sits in a smaller box. Of the ₹20.6 crore profit, roughly ₹5 crore came from the monetization of prior-year EPR (Extended Producer Responsibility) credits—recycled plastic waste credits the company was owed by the government. Strip that out, and organic PAT is ₹15.6 crore (~10% net margin). Still a year-on-year gain, but the growth is softer than the headline suggests. The margin expansion is real—operating profit margin reached 21.7%—but the profit growth story is tempered when you separate organic from one-time.
Reported vs. organic: where the earnings surprise lives
Revenue growth hit the guidance floor, not beat it
Prior guidance was 20–25% revenue growth for FY27. Q1 delivered 19.9% YoY—just at the floor, not a beat. Worse, revenue fell 0.5% quarter-on-quarter (₹156.2 Cr vs. ₹157 Cr in Q4), which is not the momentum a growth story should show. Management attributed the QoQ decline to consumer segment weakness (down 20% volume due to West Asia conflict-driven raw material cost shocks), but the near-term momentum is flagging. FY27 full-year guidance was reset to ₹670–700 Cr, which implies roughly 16–17% full-year growth—meaningfully below the prior 20–25% projection.
Margin guidance says 21.7% won't stick
The operating margin hit 21.7% in Q1—the highest in several years, driven by raw material cost optimization and a richer product mix (value-add lines like MRP and reclaim rubber gaining share). But the company guided 18–20% EBITDA margins for FY27, signaling that Q1's performance won't repeat. Management was explicit: margin expansion comes front-loaded from new product launches (TPO, rCB, PCMB ramping); the capex costs of those expansions are also front-loaded. Investors interpreted this as a reset lower, not a conservative hedge. The market vote came swift: a 3.45% drop on day 1, widening to a 9.35% loss by day 3.
Record EBITDA (>₹30 Cr) and PAT (>₹20 Cr)
✓ EBITDA ~₹34 Cr (21.7% OPM), PAT ₹20.6 Cr. Highest in 2–3 years.
Supported
Revenue grew 18–20% YoY on standalone basis
✓ 19.9% YoY delivered; just inside the range and at the guidance floor.
Supported (barely)
Industrial segment revenue up 58% YoY
Core industrial volume +27% YoY; exports +46%. The 58% includes MRP (+28% vol), reclaim rubber (+37% vol), and pricing gains. Mix-heavy, not volume-driven.
Overstated
Margins 18%+ are sustainable; no inventory gains
Q1 at 21.7%; guidance reset to 18–20%. Margin comes from raw material optimization + mix, not inventory. But ~₹5 Cr PAT from one-time EPR. Organic margin ~10% NPM.
Overstated
EPR monetization is 'integral to the recycling business'
True for ongoing EPR (₹25–30 Cr annually), but Q1's ₹5 Cr PAT comes from prior-year accrual monetization—non-recurring in timing and magnitude.
Misleading
What changed on this call
Three material shifts from prior guidance:
Revenue growth deceleration: Prior 20–25% FY27 → now ₹670–700 Cr (16–17% full-year). Q1 was peak season for infra; Q2–Q3 expected weaker by seasonality. Back-end-loaded ramp is lower than expected.
Margin guidance reset: Prior 18%+ aspiration → now 18–20% guided for FY27. Q1's 21.7% OPM flagged as front-ended by expansion capex and new geography losses (South Africa, Saudi not yet profitable). Signals Q1 margin may peak.
New product ramps visible: TPO facility to launch commercial sales Q2; rCB production Q3. ₹50–60 Cr revenue target from TPO/rCB in FY27 (~7–10% of revenue). Concrete milestone, but execution risk remains.
The bull-bear ledger
Margin expansion is structural: raw material optimization + value-add mix gains, not inventory-driven or accounting-driven.
Tire crushing capacity 88% utilized (185 ktpa); world's largest MRP at 20 ktpa; new products (TPO, rCB, PCMB) backed by capex execution (₹27 Cr Q1, ₹60 Cr planned FY27).
Vision 2029 (₹1,000 Cr revenue, 25%+ CAGR) quantified with capex roadmap (₹100 Cr FY27–28) and segment diversification (industrial, infra, consumer, steel, PCMB, TPO, rCB).
PAT +75% leans ~₹5 Cr on one-time EPR monetization; organic growth ~35%, softer than reported.
Revenue growth at guidance floor (19.9% vs 20%+ prior); QoQ revenue down 0.5%. Momentum pause signaled. FY27 growth reset to 16–17% (vs. 20–25% prior).
Consumer segment (8–10% revenue) down 20% volume due to West Asia conflict raw material cost shocks. Recovery timeline unclear; near-term headwind.
International expansion unproven: South Africa Phase 1 breakeven expected Q2; Saudi facility start pending geopolitical normalization. Q1 combined loss ~₹0.53 Cr; capex drag likely 1–2 quarters.
Margin guidance at 18–20% vs Q1's 21.7% suggests Q1 may mark a margin peak. Further expansion baked into assumptions; margin miss would trigger sharp repricing.
How the street positioned itself—and what it says about the print
The market's reaction was swift and harsh. The stock fell 3.45% on day 1 and extended the loss to 9.35% by day 3—a sell-off that tells you the Street sized up the earnings quality gap immediately. At ₹1,078.60 as of July 23, the stock is now 18.3% below its all-time high but still up 104% from the 52-week low of ₹527.45. The sharp drawdown from ATH, combined with this quarter's disappointment, suggests the market had priced in a step-change (both margin expansion AND growth re-acceleration) and is now repricing for a more modest story: steady margin (18–20%), softer growth (16–17%), and execution risk on international capex.
Ownership data shows institutional engagement has been slowly winding down: FII stake fell from 0.66% in Q1 FY26 to 0.36% by Q4 FY26, a 30-bps decline over a year. DII has been stable at 5–6%. Promoter stake remains steady at 67.6%, signaling no insider selling. The low FII fraction and recent sell-off imply the stock is now mostly owned by retail and domestic institutional buyers—a crowd that may lack the conviction or scale to defend a momentum story after an earnings miss.
The technical picture reinforces the fundamental gap: the stock sits above its 20-day (+8.8%), 50-day (+20.6%), and 200-day (+34%) moving averages, which would normally suggest bullish bias. But the RSI at 63.8 is NEUTRAL (neither overbought nor oversold), and volume is increasing—a rare pairing that signals new sellers entering the trade, not buyers getting exhausted. This is a transition market, not a bounce.
Risks, ranked by how much they should concern a holder
Margin sustainability below 18–20%: Q1 delivered 21.7% OPM but guidance reset to 18–20%, citing expansion capex, new geography losses, and normalization. If TPO/rCB ramps slow or utilization disappoints, margins could compress faster.
HighA 100–200 bps margin miss on ₹670–700 Cr revenue would wipe ₹7–14 Cr PAT (>30% downside to earnings base). Valuations have priced in margin expansion; a retreat triggers re-rating.
Organic revenue growth stays below 16–17%: Q1 at 19.9% guidance floor; full-year guided to 16–17%. If consumer segment stays down 20% and infra plateaus at 7% YoY, organic growth lags even revised guidance.
HighInvestors bought the Vision 2029 thesis (25%+ CAGR to ₹1,000 Cr). A year of sub-15% growth signals the medium-term trajectory is steeper than implied; confidence in CAGR erodes.
International expansion proves loss-making longer than expected: South Africa Phase 1 breakeven expected Q2, Phase 2 (9k tpa) ramping Q2–Q3. Saudi facility start delayed pending geopolitical normalization. Q1 combined loss ~₹0.53 Cr.
High₹100 Cr capex FY27–28 represents 5–8% of revenue in capex intensity. If ROI slips below 15%, FY29 margin target erodes. Debt to fund capex may spike if cash generation weakens.
EPR credits run down faster than expected: Q1 monetized ₹25 Cr prior-year accrual at ₹2,500/unit. Recurring EPR ₹25–30 Cr annually at PBT level, but if plastic waste collection slows or government credit-price softens, contribution shrinks.
Medium₹5 Cr PAT hit Q1 from EPR. If recurring contribution halves, organic PAT pressured by ₹2–3 Cr annually. Modest in absolute terms, but shifts the organic growth narrative.
Consumer segment recovery takes 2+ quarters: Down 20% volume Q1 due to raw material cost shocks. Management expects 'market stabilization' but no timeline. If binder/synthetic grass prices stay elevated, projects stay delayed.
MediumConsumer is 8–10% of revenue; a 20% volume hit is ~₹1–2 Cr annual run-rate drag. Not large enough to derail guidance, but erodes confidence in diversification benefit.
Geopolitical escalation disrupts Oman/Saudi/bitumen supply: West Asia conflict already hit consumer segment and bitumen supply. Oman at 78% utilization; Saudi facility start contingent on normalization.
MediumOman is a margin-recovery story; Saudi is a growth story. Geopolitical delay by 1–2 years pushes Vision 2029 toward infeasible. Also increases political risk premiums for debt.
The debate
What to watch next
1 · Q2 organic PAT and margin delivery
Can management hold 18%+ margins without the ₹5 Cr EPR tailwind? If Q2 organic PAT exceeds ₹15 Cr and OPM stays ≥18%, the margin guidance holds and the debate shifts to growth. If Q2 organic PAT drops below ₹13 Cr or OPM falls below 17%, margins are eroding faster than guided, and FY27 targets are at risk.
2 · TPO commercial launch and Q2–Q3 revenue contribution
Management targeted ₹50–60 Cr TPO/rCB contribution in FY27 (7–10% of revenue). Q2 should show TPO sales in run-rate; Q3 adds rCB production. If Q2 TPO revenue comes in below ₹8 Cr or shows weak order intake, the growth ramp is stalling and FY27 guidance (₹670–700 Cr) is at risk.
3 · Consumer segment stabilization and pricing trends
Consumer segment is down 20% volume. Early stabilization signals (binder/synthetic grass prices softening, project orders flowing) would validate management's narrative. If Q2 consumer segment stays down >15% or raw material costs remain elevated, the near-term headwind extends and 16–17% growth becomes a ceiling.
Tinna Rubber's Q1 earnings are a study in optics vs. substance. Reported profit jumped 75%; organic profit grew ~35% when you strip the one-time EPR benefit and assume organic margin at 10% NPM. Reported revenue met guidance floor (19.9% YoY) but flagged fatigue (QoQ down 0.5%, consumer segment down 20% volume). Guidance was reset: revenue growth from 20–25% to 16–17%, margins from 18%+ aspiration to 18–20% guided. The Street read this correctly and repriced 9.35% lower by day 3.
The narrative remains intact—Vision 2029 at ₹1,000 Cr is credible, capex is being deployed, and new products are launching. But Q1 was not the inflection into simultaneous margin expansion + revenue re-acceleration. It was a margin-expansion quarter that came at the cost of revenue deceleration and capex drag. For holders, this is a digest-and-patience play: the margin is real, the growth is slower than prior guidance, and the payoff sits in FY27–FY29 if TPO/rCB ramps and consumer/geopolitical headwinds fade.
The number to track from here is organic PAT (excluding EPR) and whether Q2–Q3 margins stay above 18%. If they do, the investment thesis survives; if they slide below 17%, the FY29 target (18%+ margins) becomes aspirational rather than achievable. At current valuations, the stock is pricing in steady execution and a credible path to ₹1,000 Cr by FY29. That is a reasonable long-term bet, but it requires no margin disappointments and successful international expansion. Given the Q1 miss and guidance reset, the bar for upside surprise has risen sharply.